Most cases of leukopenia are associated with a low number of granulocytes.
Decreased production of granulocytes may be caused by marrow failure, infiltration of the marrow by leukemic cells or metastatic cancer cells, suppression of granulocyte production by certain drugs, and vitamin B12 or folate deficiency.
There may be an accelerated removal of granulocytes following exposure to certain drugs, as part of an autoimmune disorder, in certain infections, or from splenic sequestration of granulocytes.
Suggested Additional Lab Testing
Most important test: WBC count and differential
Peripheral blood smear and bone marrow aspirate, with or without bone marrow biopsy, is informative in the diagnosis of certain leukopenias.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Varenicline Reduces Heavy Drinking, Cigarette Smoking in Men With Alcohol Use Disorder
- Anhedonia and Suicidal Ideation Linked Independent of Major Affective Disorders
- Cognitive Insight Impairment May Precede Neurocognitive Decline in Schizophrenia
- Rarity of Late-Onset ADHD: Symptoms Linked to Other Causes
- Predictive Psychiatric Genetic Testing for At-Risk Minors: Risk vs Reward
- Amber Lenses Before Bed Improve Insomnia Symptoms
- Pregnancy and Bipolar Disorder: Expert Interview With Leena Mittal, MD
- Preventing Suicide in Prison Inmates
- Cannabis Use in Adolescence May Mediate Future Hypomania
- Lurasidone Monotherapy Safe, Efficacious in Children, Adolescents With Bipolar Depression
- Quality Improvement Noted With Geriatric Assessment Note Intervention
- Sexual Harassment: Response to a National Crisis
- Involuntary Brain Responses to Sensory Pattern Changes in PTSD
- Smoking Cessation Medication Associated With Increased Risk of Cardiovascular Events
- Relationship Between Neuroanatomic Abnormalities and Behavioral, Cognitive Impairment in Individuals At Risk for ASD